A medical device company based in Irvine, California, Diality Inc., has appointed Peter Donato as its new chief financial officer. Diality is known for developing the Moda-flx™ Hemodialysis System and is currently enrolling patients in the PRESCRIBE Diality Home Hemodialysis Clinical Trial for the system. The company is gearing up for a limited market release slated for 2027. Donato brings with him a wealth of experience, boasting nearly 35 years in financial leadership roles.